Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1716 ARTÍCULOS , VIENDO DEL 1126 AL 1140

Multi-mechanical waves against Alzheimer's disease pathology: a systematic review

Monteiro F, Sotiropoulos I, Carvalho Ó, Sousa N, Silva FS.

Transl Neurodegener. 2021 Sep 24;10(1):36. doi: 10.1186/s40035-021-00256-z.

Effects of Supplementation with Folic Acid and Its Combinations with Other Nutrients on Cognitive Impairment and Alzheimer's Disease: A Narrative Review

Puga AM, Ruperto M, Samaniego-Vaesken ML, Montero-Bravo A, Partearroyo T, Varela-Moreiras G.

Nutrients. 2021 Aug 26;13(9):2966. doi: 10.3390/nu13092966.

Driving and Alzheimer's dementia or mild cognitive impairment: a systematic review of the existing guidelines emphasizing on the neurologist's role

Stamatelos P, Economou A, Stefanis L, Yannis G, Papageorgiou SG.

Neurol Sci. 2021 Dec;42(12):4953-4963. doi: 10.1007/s10072-021-05610-7. Epub 2021 Sep 28.

Machine learning methods for predicting progression from mild cognitive impairment to Alzheimer's disease dementia: a systematic review

Grueso S, Viejo-Sobera R.

Alzheimers Res Ther. 2021 Sep 28;13(1):162. doi: 10.1186/s13195-021-00900-w.

Editorial: How Will Aducanumab Approval Impact AD Research?

Weiner MW, Aisen PS, Beckett LA, Green RC, Jagust W, Morris JC, Okonkwo O, Perrin RJ, Petersen RC, Rivera Mindt M, Saykin AJ, Shaw LM, Toga AW, Trojanowski JQ.

J Prev Alzheimers Dis. 2021;8(4):391-392. doi: 10.14283/jpad.2021.46.

Donanemab (LY3002813) Phase 1b Study in Alzheimer's Disease: Rapid and Sustained Reduction of Brain Amyloid Measured by Florbetapir F18 Imaging

Lowe SL, Duggan Evans C, Shcherbinin S, Cheng YJ, Willis BA, Gueorguieva I, Lo AC, Fleisher AS, Dage JL, Ardayfio P, Aguiar G, Ishibai M, Takaichi G, Chua L, Mullins G, Sims JR.

J Prev Alzheimers Dis. 2021;8(4):414-424. doi: 10.14283/jpad.2021.56.

Editorial: Alzheimer's Disease Research in Japan: A Short History, Current Status and Future Perspectives toward Prevention

Iwatsubo T, Niimi Y, Akiyama H.

J Prev Alzheimers Dis. 2021;8(4):462-464. doi: 10.14283/jpad.2021.38.

Immunotherapy for Alzheimer's Disease: Current Scenario and Future Perspectives

Usman MB, Bhardwaj S, Roychoudhury S, Kumar D, Alexiou A, Kumar P, Ambasta RK, Prasher P, Shukla S, Upadhye V, Khan FA, Awasthi R, Shastri MD, Singh SK, Gupta G, Chellappan DK, Dua K, Jha SK, Ruokolainen J, Kesari KK, Ojha S, Jha NK.

J Prev Alzheimers Dis. 2021;8(4):534-551. doi: 10.14283/jpad.2021.52.

Cognitive Dysfunction in Cats: Update on Neuropathological and Behavioural Changes Plus Clinical Management

Sordo L, Gunn-Moore DA.

Vet Rec. 2021 Jan;188(1):e3. doi: 10.1002/vetr.3. Epub 2021 Jan 12.

Going round in circles-The Papez circuit in Alzheimer's disease

Forno G, Lladó A, Hornberger M.

Eur J Neurosci. 2021 Nov;54(10):7668-7687. doi: 10.1111/ejn.15494. Epub 2021 Nov 2.

Erzhi pills ameliorate cognitive dysfunction and alter proteomic hippocampus profiles induced by d-galactose and Aβ(1-)(40) injection in ovariectomized Alzheimer's disease model rats

Xie Y, Yan B, Hou M, Zhou M, Liu C, Sun M, He K, Fang C, Chen Y, Huang L.

Pharm Biol. 2021 Dec;59(1):1402-1414. doi: 10.1080/13880209.2021.1990353.

Potential new therapeutic target for Alzheimer's disease: Glucagon-like peptide-1

Liu XY, Zhang N, Zhang SX, Xu P.

Eur J Neurosci. 2021 Nov;54(10):7749-7769. doi: 10.1111/ejn.15502. Epub 2021 Nov 7.

MicroRNA-455-5p/CPEB1 pathway mediates Aβ-related learning and memory deficits in a mouse model of Alzheimer's disease

Xiao G, Chen Q, Zhang X.

Brain Res Bull. 2021 Dec;177:282-294. doi: 10.1016/j.brainresbull.2021.10.008. Epub 2021 Oct 20.

Inhibition of Astrocytic Histamine N-Methyltransferase as a Possible Target for the Treatment of Alzheimer's Disease

Flores-Clemente C, Nicolás-Vázquez MI, Mera Jiménez E, Hernández-Rodríguez M.

Biomolecules. 2021 Sep 26;11(10):1408. doi: 10.3390/biom11101408.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias